Enliven Therapeutics logo

Enliven Therapeutics Share Price (NASDAQ: ELVN)

$20.85

1.01

(5.09%)

Last updated on

Check the interactive Enliven Therapeutics Stock chart to analyse performance

Enliven Therapeutics stock performance

as on August 23, 2025 at 1:29 AM IST

  • Today's Low:$19.84
    Today's High:$21.05

    Day's Volatility :5.77%

  • 52 Weeks Low:$13.30
    52 Weeks High:$30.03

    52 Weeks Volatility :55.71%

Enliven Therapeutics Stock Returns

PeriodEnliven Therapeutics IncIndex (Russel 2000)
3 Months
30.43%
0.0%
6 Months
-2.32%
0.0%
1 Year
-9.05%
0.0%
3 Years
-12.19%
-8.6%

Enliven Therapeutics Inc Key Stats

Check Enliven Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$19.84
Open
$19.835
Today's High
$21.05
Today's Low
$19.835
Market Capitalization
$1.2B
Today's Volume
$830.4K
52 Week High
$30.03
52 Week Low
$13.3
Revenue TTM
$0.0
EBITDA
$-113.9M
Earnings Per Share (EPS)
$-1.99
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-25.26%

Stock Returns calculator for Enliven Therapeutics Stock including INR - Dollar returns

The Enliven Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Enliven Therapeutics investment value today

Current value as on today

₹95,245

Returns

₹4,755

(-4.76%)

Returns from Enliven Therapeutics Stock

₹9,071 (-9.07%)

Dollar Returns*

₹4,316 (+4.32%)

Indian investors sentiment towards Enliven Therapeutics Stock

300%

Period: Jul 25, 2025 to Aug 24, 2025. Change in 30 Days versus previous period

Search interest for Enliven Therapeutics Stock from India on INDmoney has increased by 300% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Enliven Therapeutics Stock

Rating
Trend

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Enliven Therapeutics(by analysts ranked 0 to 5 stars)

Enliven Therapeutics Share Price Target

What analysts predicted

Upside of 97.84%

Target:

$41.25

Current:

$20.85

Enliven Therapeutics share price target is $41.25, a slight Upside of 97.84% compared to current price of $20.85 as per analysts' prediction.

Enliven Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, ELVN stock has moved up by 27.2%
  • ELVN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.6% return, outperforming this stock by 75.9%

Enliven Therapeutics Technicals Summary

Sell

Neutral

Buy

Enliven Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Enliven Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Enliven Therapeutics Inc logo
-1.63%
-2.32%
-9.05%
-12.19%
-12.19%
Regeneron Pharmaceuticals, Inc. logo
4.66%
-17.37%
-50.86%
-2.39%
-3.46%
Beone Medicines Ltd logo
7.62%
21.35%
57.45%
78.28%
25.05%
Vertex Pharmaceuticals Incorporated logo
-15.87%
-17.97%
-18.14%
35.67%
45.07%
Alnylam Pharmaceuticals, Inc. logo
38.16%
82.49%
68.79%
112.36%
238.79%

About Enliven Therapeutics Inc

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, a small molecule kinase inhibitor which is in Phase 1 clinical trial to treat adults with chronic myeloid leukemia; and ELVN-002, a CNS penetrant and irreversible HER2 inhibitor that is in Phase 1 clinical trial for the treatment of non-small cell lung cancer (NSCLC) and other HER2 driven cancers and solid tumors. The company is headquartered in Boulder, Colorado.
Organization
Enliven Therapeutics
Employees
63
CEO
Mr. Samuel S. Kintz M.B.A.
Industry
Miscellaneous

Key Management of Enliven Therapeutics Inc

NameTitle
Mr. Samuel S. Kintz M.B.A.
Co-Founder, CEO, Secretary & Director
Dr. Joseph P. Lyssikatos Ph.D.
Co-Founder & Chief Scientific Officer
Dr. Helen Louise Collins M.D.
Chief Medical Officer
Mr. Anish Patel Pharm.D.
Co-Founder & COO
Mr. Benjamin Hohl
CFO & Head of Corporate Development
Dr. Galya D. Blachman Esq., Ph.D.
Chief Legal Officer & Head of Business Development

Important FAQs about investing in ELVN Stock from India :

What is Enliven Therapeutics share price today?

Enliven Therapeutics share price today is $20.85 as on at the close of the market. Enliven Therapeutics share today touched a day high of $21.05 and a low of $19.84.

What is the 52 week high and 52 week low for Enliven Therapeutics share?

Enliven Therapeutics share touched a 52 week high of $30.03 and a 52 week low of $13.30. Enliven Therapeutics stock price today i.e. is closed at $20.85, lower by 30.57% versus the 52 week high.

How to invest in Enliven Therapeutics Stock (ELVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Enliven Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Enliven Therapeutics Shares that will get you 0.0719 shares as per Enliven Therapeutics share price of $20.85 per share as on August 23, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Enliven Therapeutics Stock (ELVN) from India?

Indian investors can start investing in Enliven Therapeutics (ELVN) shares with as little as ₹87.521 or $1 (as of August 25, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.21 in Enliven Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 25, 2025). Based on Enliven Therapeutics share’s latest price of $20.85 as on August 23, 2025 at 1:29 AM IST, you will get 0.4796 shares of Enliven Therapeutics. Learn more about fractional shares .

What are the returns that Enliven Therapeutics has given to Indian investors in the last 5 years?

Enliven Therapeutics stock has given -12.19% share price returns and 18.0% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?